Konrad Wagner studied chemistry (B.Sc.) at the Friedrich-Schiller-Universität Jena. After his Bachelor thesis (Synthesis of Blebbistatin and derivatives) he startet his Master studies at Jena with focus on synthetic chemistry and drug design. During his Master thesis he worked on Arylphosphosphoniumsalts of N-Heteroaromatic compounds and their reactions with C, N, O, and S-nucleophiles. He finished his thesis in 2020 and started his PhD studies a year later in the working group "Anti-Infective Drug Discovery" of Dr. Martin Empting. He will focus his research on the synthesis and optimization of new drug candidates for the new antitumor and diabetes target IMP2 as well as the synthesis and optimization of anti-viral drugs against HSV.